2018
DOI: 10.1016/j.jsbmb.2017.08.008
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of 19-norcalcitriol analogs with elongated side chain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 17 publications
0
1
0
Order By: Relevance
“…Figure 28 (2018-2019) [365][366][367][368][369][370][371][372][373][374][375][376][377][378]. 21-nor-17(S)-Methyl-20(22),23(24)-didehydro-26,26, 26,27,27,27-hexafluoro-1α,25-dihydroxyvitamin D 3 (1600) [368] bound strongly to VDR ligand binding domain and induced VDR transcriptional activity.…”
Section: Resultsmentioning
confidence: 99%
“…Figure 28 (2018-2019) [365][366][367][368][369][370][371][372][373][374][375][376][377][378]. 21-nor-17(S)-Methyl-20(22),23(24)-didehydro-26,26, 26,27,27,27-hexafluoro-1α,25-dihydroxyvitamin D 3 (1600) [368] bound strongly to VDR ligand binding domain and induced VDR transcriptional activity.…”
Section: Resultsmentioning
confidence: 99%
“…Structural fragments 1 and 2 represent modified side chains precursors. This part of vitamins D is often chemically modified and, owing to the flexibility of this side chain, it significantly influences the binding affinity of the analogues with VDR [30]. For instance, replacing either the C26-and C27-methyl groups with ethyl moieties resulted in the superagonist, KH1060, which binds to VDR with high affinity as well as decreased calcemic side effects [28].…”
Section: Introductionmentioning
confidence: 99%